David M Kern

20PUBLICATIONS
26CO-AUTHORS
Econometric and statistical methodsCentral nervous systemHealth and ecological risk assessmentPharmacogenomicsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 18, 2026
Comment on Esketamine 5 Years After Approval: Welcome New Data With Continuing Questions.

Muhammad Ahmed, Patricia Cabrera, Teodora Doherty

|Feb 26, 2026
Lack of association between the brain penetrance of calcium channel blockers and the incidence of neuropsychiatric outcomes: a retrospective, multidatabase cohort study.

David M Kern, Justin Bohn, Michael P Maher

|Sep 10, 2025
Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis Almost 5 Years After First Approval.

Gerard Sanacora, Muhammad Ahmed, Brianne Brown

|Jun 04, 2025
Large-scale Empirical Identification of Candidate Comparators for Pharmacoepidemiological Studies.

Justin Bohn, James P Gilbert, Christopher Knoll

|Mar 03, 2024
Incidence of mental health diagnoses during the COVID-19 pandemic: a multinational network study.

Yi Chai, Kenneth K C Man, Hao Luo

|Jul 21, 2023
Suicide-specific mortality among patients with treatment-resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone.

David M Kern, Carla M Canuso, Ella Daly

Pageof 4

Frequent Collaborators

3 joint publications

M Soledad Cepeda

2 joint publications

Amit D Raval

1 joint publications

Kathryn Duensing

1 joint publications

Robert Twillman